The cost of purchasing and transporting nitric acid as compared to upgrading from ammonia, combined with higher maintenance and other costs, reduced our Q3 EBITDA by approximately $6,000,000 Page 7 bridges our $9,000,000 of 3rd quarter adjusted EBITDA to our record $50,000,000 EBITDA for the Q3 of 2022. The impact of weaker selling prices For our products relative to last year is the major factor in the year over year change in EBITDA. Page 8 provides a summary of our key balance sheet and cash flow metrics. We generated cash flow from operations $17,000,000 and had capital expenditures of approximately $9,000,000 translating into more than $8,000,000 free cash flow. Despite the pricing headwinds, year to date, we generated approximately $120,000,000 in cash flow from operations with $41,000,000 in capital expenditures, translating into nearly $80,000,000 of free cash flow and a free cash flow conversion rate of over 70 We expect capital expenditures for the 4th quarter to be approximately $15,000,000 to $20,000,000 with CapEx for the full year of approximately $60,000,000 Looking forward to the 4th quarter, Nitrogen prices are firming up.